HOME
|
CONTACT
|
SITEMAP
HOME
CORPORATE
VISION
MANAGEMENT TEAM
BOARD OF DIRECTORS
CLINICAL ADVISORY BOARD
SCIENTIFIC ADVISORY BOARD
CORPORATE GOVERNANCE
TECHNOLOGY
NTx®-265 (Stroke)
NTx®-428 (Brain Trauma)
NTx®-488 (Multiple Sclerosis)
PUBLICATIONS
MEDIA CENTRE
GLOSSARY
INVESTORS
STOCK INFORMATION
FINANCIAL REPORTS
STROKE MARKET
SHAREHOLDER SERVICES
INVESTOR CONTACT
NEWS & EVENTS
PRESS RELEASES
EVENTS
PRESENTATIONS
LINKS
TSX - Venture:
SSS
PRESS RELEASES
EVENTS
PRESENTATIONS
LINKS
CORPORATE EVENTS
Stem Cell Therapeutics' Annual General Meeting
May 19, 2010
Calgary, AB
2010 BIO International Convention
May 3-6, 2010
Chicago, IL
BioFinance 2010
April6-8, 2010
Toronto, ON
BIOTECanada Whistler CEO Summit
January 23, 2010
Whistler, BC
American Stroke Association's International Stroke Conference 2010
February 24-26, 2010
San Antonio, Texas
Stem Cell Therapies Public Forum: "From the Lab to the Bedside"
November 25, 2009
Calgary, AB
2009 Neural Restoration Workshop
November 12, 2009
Albuquerque, New Mexico
Banff Venture Forum 2009
October 1-2, 2009
Banff, Alberta
2009 World Stem Cell Summit
September 21-22, 2009
Baltimore, Maryland
25TH Congress of the European Committee for Treatment and Research in Multiple Sclerosis
September 9-12, 2009
Dusseldorf, Germany
STOCK QUOTE
Symbol:
TSX:SSS
Last Trade:
0.065
Change:
+8.33%
Volume:
243549
Date:
9/3/2010
Time:
3:48pm
Note: Quotes are delayed. For informational purposes only.
LETTER TO SHAREHOLDERS
+
2009 Letter to Shareholders
FACT SHEET
©2004 - 2010 Stem Cell Therapeutics - All rights reserved
Home
|
Site Map
|
Terms Of Use
|
Contact Us